JB/CALL/POLE GROU/19.5/0.125/20.09.24 | Market Closed - Swiss Exchange 11:20:00 2024-05-31 am EDT | ||
| 1.83 CHF | +7.65% |
|
| Current month | +17.31% | ||
| 1 month | +17.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 1.83 | +7.65% |
| 24-05-30 | 1.7 | +3.03% |
| 24-05-29 | 1.65 | -6.78% |
| 24-05-28 | 1.77 | -1.12% |
| 24-05-27 | 1.79 | +4.68% |
Delayed Quote Swiss Exchange
Last update May 31, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPGTJB | |
| ISIN | CH1276780108 |
| Date issued | 2023-07-21 |
| Strike | 19.5 CHF |
| Maturity | 2024-09-20 (112 Days) |
| Parity | 8 : 1 |
| Emission price | 0.66 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 1.9 CHF |
|---|---|
| Lowest since issue | 0.17 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.54% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
32.8
EUR
Average target price
25.12
EUR
Spread / Average Target
-23.42%
- Stock Market
- Warrants
- PPGTJB Warrant
